www.fool.com
Open in
urlscan Pro
172.64.147.90
Public Scan
Submitted URL: https://email.analystratings.net/ls/click?upn=u001.WeKo-2BCuHku2kJmVIsYmGxuYr2srlLtYnnWDpKGijlvvbzplfpd-2FFtizxHxvIQR-2BDaDu8mg2F...
Effective URL: https://www.fool.com/investing/2024/12/27/prediction-this-will-be-amazons-next-big-buyout/
Submission: On December 27 via api from BE — Scanned from CA
Effective URL: https://www.fool.com/investing/2024/12/27/prediction-this-will-be-amazons-next-big-buyout/
Submission: On December 27 via api from BE — Scanned from CA
Form analysis
4 forms found in the DOMPOST javascript:void(0)
<form action="javascript:void(0)" data-ftm-derby="9891" data-ftm-heat="15422" data-ftm-pit="16739" data-ftm-veh="in_line_article_pitch" data-impression-id="1d567301-0863-4faa-bd22-ae09c2fde0a9" id="ecapWidgetForm" method="POST"><input id="aid"
name="aid" type="hidden" value="11010"> <input id="src" name="src" type="hidden" value="isaediica0000008"><label style="display: inline-block;"><span class="email-text sr-only">Enter Email Address:</span><input 0="" class="email"
data-no-resize="true" id="email-input" margin-right:="" name="email" placeholder="Enter Email" type="email" data-uw-rm-form="nfx"></label> <input aria-label="Get Started Now" class="foolcom-btn-cyan foolcom-btn" name="button" type="submit"
value="Sign Up" data-uw-rm-form="nfx"><input id="pitchClickUrl" name="pitchClickUrl" type="hidden"
value="https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=1d567301-0863-4faa-bd22-ae09c2fde0a9&url=https%3A%2F%2Fwww.fool.com%3Fftm_cam%3Dsa-breakfast-news%26ftm_veh%3Din_line_article_pitch%26ftm_pit%3D16739%26aid%3D11010%26source%3Disaediica0000008"><input
id="ftm_pit" name="ftm_pit" type="hidden" value="16739"><input id="ftm_cam" name="ftm_cam" type="hidden" value="sa-breakfast-news"><input id="ftm_veh" name="ftm_veh" type="hidden" value="in_line_article_pitch"><input id="prevent-ecap-redirect"
name="prevent-ecap-redirect" type="hidden" value="True"><input id="InfoTrackClickImpression" name="InfoTrackClickImpression" type="hidden" value="1d567301-0863-4faa-bd22-ae09c2fde0a9"></form>
<form class="sm:flex max-w-740 mb-12px" id="ecap-form" onsubmit="handleEcapFormSubmit(event)">
<div class="font-bold" id="ecap-submit-message"></div>
<div class="mt-20px">
<div class="text-sm">By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. Please read our
<a aria-label="Privacy Statement - open in a new tab" data-uw-rm-ext-link="" href="https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=1d567301-0863-4faa-bd22-ae09c2fde0a9&url=https%3A%2F%2Fwww.fool.com%2Flegal%2Fprivacy-statement%2F%3Fftm_cam%3Dsa-breakfast-news%26ftm_veh%3Din_line_article_pitch%26ftm_pit%3D16739%26source%3D%26aid%3D" rel="nofollow" target="_blank" uw-rm-external-link-id="https://www.fool.com/legal/privacy-statement/$privacystatement">Privacy Statement</a>
and
<a aria-label="Terms & Conditions - open in a new tab" data-uw-rm-ext-link="" href="https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=1d567301-0863-4faa-bd22-ae09c2fde0a9&url=https%3A%2F%2Fwww.fool.com%2Flegal%2Fterms-and-conditions%2Ffool-rules%2F%3Fftm_cam%3Dsa-breakfast-news%26ftm_veh%3Din_line_article_pitch%26ftm_pit%3D16739%26source%3D%26aid%3D" rel="nofollow" target="_blank" uw-rm-external-link-id="https://www.fool.com/legal/terms-and-conditions/fool-rules/$terms&conditions">Terms & Conditions</a>.
</div>
<input id="prevent-ecap-redirect" name="prevent-ecap-redirect" type="hidden" value="True">
</div>
</form>
POST javascript:void(0)
<form action="javascript:void(0)" data-ftm-derby="9893" data-ftm-heat="15420" data-ftm-pit="16660" data-ftm-veh="foolcom_sidebar_service" data-impression-id="174d68ff-f178-44a8-aa2b-e5c959660415" id="ecapWidgetForm" method="POST"><input id="aid"
name="aid" type="hidden" value="11010"> <input id="src" name="src" type="hidden" value="isaedisdb0000010"><label style="display: inline-block;"><span class="email-text sr-only">Enter Email Address:</span><input 0="" class="email"
data-no-resize="true" id="email-input" margin-right:="" name="email" placeholder="Enter Email" type="email" data-uw-rm-form="nfx"></label> <input aria-label="Get Started Now" class="foolcom-btn-cyan foolcom-btn" name="button" type="submit"
value="Sign Up" data-uw-rm-form="nfx"><input id="pitchClickUrl" name="pitchClickUrl" type="hidden"
value="https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=174d68ff-f178-44a8-aa2b-e5c959660415&url=https%3A%2F%2Fwww.fool.com%3Fftm_cam%3Dsa-breakfast-news%26ftm_veh%3Dfoolcom_sidebar_service%26ftm_pit%3D16660%26aid%3D11010%26source%3Disaedisdb0000010"><input
id="ftm_pit" name="ftm_pit" type="hidden" value="16660"><input id="ftm_cam" name="ftm_cam" type="hidden" value="sa-breakfast-news"><input id="ftm_veh" name="ftm_veh" type="hidden" value="foolcom_sidebar_service"><input id="prevent-ecap-redirect"
name="prevent-ecap-redirect" type="hidden" value="True"><input id="InfoTrackClickImpression" name="InfoTrackClickImpression" type="hidden" value="174d68ff-f178-44a8-aa2b-e5c959660415"></form>
<form class="sm:flex max-w-740 mb-12px" id="ecap-form" onsubmit="handleEcapFormSubmit(event)">
<div class="font-bold" id="ecap-submit-message"></div>
<div class="mt-20px">
<div class="text-sm">By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. Please read our
<a aria-label="Privacy Statement - open in a new tab" data-uw-rm-ext-link="" href="https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=174d68ff-f178-44a8-aa2b-e5c959660415&url=https%3A%2F%2Fwww.fool.com%2Flegal%2Fprivacy-statement%2F%3Fftm_cam%3Dsa-breakfast-news%26ftm_veh%3Dfoolcom_sidebar_service%26ftm_pit%3D16660%26source%3D%26aid%3D" rel="nofollow" target="_blank" uw-rm-external-link-id="https://www.fool.com/legal/privacy-statement/$privacystatement">Privacy Statement</a>
and
<a aria-label="Terms & Conditions - open in a new tab" data-uw-rm-ext-link="" href="https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=174d68ff-f178-44a8-aa2b-e5c959660415&url=https%3A%2F%2Fwww.fool.com%2Flegal%2Fterms-and-conditions%2Ffool-rules%2F%3Fftm_cam%3Dsa-breakfast-news%26ftm_veh%3Dfoolcom_sidebar_service%26ftm_pit%3D16660%26source%3D%26aid%3D" rel="nofollow" target="_blank" uw-rm-external-link-id="https://www.fool.com/legal/terms-and-conditions/fool-rules/$terms&conditions">Terms & Conditions</a>
</div>
<input id="prevent-ecap-redirect" name="prevent-ecap-redirect" type="hidden" value="True">
</div>
</form>
Text Content
Skip to main contentEnable accessibility for low visionOpen the accessibility menu Search ▲ S&P 500 +176% | ▲ Stock Advisor +922% Join The Motley Fool Accessibility Log In Help Accessibility Menu Our Services Stock Market News angle-down Stock News * Stock Market News * Market Movers * Tech Stock News * Market Trends * Consumer Stock News * Crypto News * Industrial Stock News Markets * Stock Market Indexes Today * Most Active Stocks Today * Today's Biggest Stock Gainers * Today's Biggest Stock Losers * Largest Market Cap Companies * Market Research * 📨 Breakfast News Best Buys * Top Stocks to Buy Now * Best ETFs to Buy * Best AI Stocks * Best Growth Stocks * Dividend Kings * Best Index Funds * Next Cryptos to Explode Industries to Invest In * Technology * Energy * Real Estate * Healthcare * Consumer Goods * Materials * Industrials How to Invest angle-down Investing 101 * How to Invest Money * What to Invest In * How to Invest in Stocks * How to Invest in ETFs * How to Invest in Index Funds * How to Invest in Bonds * Financial Dictionary Stock Market Basics * Stock Market 101 * Types of Stocks * Stock Market Sectors * Stock Market Indexes * What Are Stock Splits? * What Is Compound Interest? * After Hours Trading Start Investing * How to Buy Stock * Best Brokers for Beginners * Best Brokerage Accounts * Good Time to Buy Stocks * How Many Shares to Buy? * Portfolio Diversification * Long Term Investing Strategies Companies to Invest In * Magnificent Seven Companies * Warren Buffett Investments * Investing in ChatGPT * Investing in SpaceX * Investing in OpenAI * Investing in Nvidia * Investing in Databricks Retirement angle-down Retirement Essentials * Retirement 101 * Types of Retirement Accounts * How to Contribute to 401k/IRA? * Strategies to Save for Retirement * Asset Allocation for My Age * Best IRA Brokerage Accounts * Withdrawal Rules for 401(k) Plans Social Security Benefits * Social Security 101 * When to Start Social Security? * Full Retirement Age * COLAs * Calculate Your SS Benefits * Collecting Spousal Benefits * Maximize Social Security Benefit Planning for Retirement * How Much Do I Need to Retire? * When To Retire * 401(k) Plans * 403(b) Plans * Roth IRA Plans * IRA Plans * HSA Plans Retired: What Now? * Complete Retirement Guide * Best & Worst States to Retire * Average Retirement Savings * Moving for Retirement * Healthcare in Retirement * Understanding Taxes in Retirement * 401(k) Minimum Distributions Personal Finance angle-down Credit Cards * Best Credit Cards * Compare Credit Cards * Credit Card Reviews * Credit Card Guides and Tools Bank & Loans * Best Savings Accounts * Bank Reviews * Best Personal Loans * Personal Loan Reviews Homebuying * Best Mortgage Lenders * Current Mortgage Rates * Mortgage Lender Reviews * Guide to Mortgages Insurance * Auto Insurance * Home Insurance * Life Insurance * Pet Insurance About Us angle-down Our Purpose: To make the world smarter, happier, and richer. Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on Fool.com, personal finance education, top-rated podcasts, and non-profit The Motley Fool Foundation. Who Is the Motley Fool? * About Us * Contact Us * Investing Philosophy * Motley Fool Money * The Motley Fool Foundation * Reviews * Publishing Standards Fool Podcasts * Podcasts Home * Motley Fool Money * Rule Breaker Investing Social Media * Facebook * Twitter * YouTube * Discussion Boards * CAPS - Stock Picking Community Other Services * Newsroom * Become an Affiliate Partner Top 10 Stocks to Buy Now Bars Times Search * Our Services * Stock Market News angle-down angle-up Stock News * Stock Market News * Market Movers * Tech Stock News * Market Trends * Consumer Stock News * Crypto News * Industrial Stock News Markets * Stock Market Indexes Today * Most Active Stocks Today * Today's Biggest Stock Gainers * Today's Biggest Stock Losers * Largest Market Cap Companies * Market Research * 📨 Breakfast News Best Buys * Top Stocks to Buy Now * Best ETFs to Buy * Best AI Stocks * Best Growth Stocks * Dividend Kings * Best Index Funds * Next Cryptos to Explode Industries to Invest In * Technology * Energy * Real Estate * Healthcare * Consumer Goods * Materials * Industrials * How to Invest angle-down angle-up Investing 101 * How to Invest Money * What to Invest In * How to Invest in Stocks * How to Invest in ETFs * How to Invest in Index Funds * How to Invest in Bonds * Financial Dictionary Stock Market Basics * Stock Market 101 * Types of Stocks * Stock Market Sectors * Stock Market Indexes * What Are Stock Splits? * What Is Compound Interest? * After Hours Trading Start Investing * How to Buy Stock * Best Brokers for Beginners * Best Brokerage Accounts * Good Time to Buy Stocks * How Many Shares to Buy? * Portfolio Diversification * Long Term Investing Strategies Companies to Invest In * Magnificent Seven Companies * Warren Buffett Investments * Investing in ChatGPT * Investing in SpaceX * Investing in OpenAI * Investing in Nvidia * Investing in Databricks * Retirement angle-down angle-up Retirement Essentials * Retirement 101 * Types of Retirement Accounts * How to Contribute to 401k/IRA? * Strategies to Save for Retirement * Asset Allocation for My Age * Best IRA Brokerage Accounts * Withdrawal Rules for 401(k) Plans Social Security Benefits * Social Security 101 * When to Start Social Security? * Full Retirement Age * COLAs * Calculate Your SS Benefits * Collecting Spousal Benefits * Maximize Social Security Benefit Planning for Retirement * How Much Do I Need to Retire? * When To Retire * 401(k) Plans * 403(b) Plans * Roth IRA Plans * IRA Plans * HSA Plans Retired: What Now? * Complete Retirement Guide * Best & Worst States to Retire * Average Retirement Savings * Moving for Retirement * Healthcare in Retirement * Understanding Taxes in Retirement * 401(k) Minimum Distributions * Personal Finance angle-down angle-up Credit Cards * Best Credit Cards * Compare Credit Cards * Credit Card Reviews * Credit Card Guides and Tools Bank & Loans * Best Savings Accounts * Bank Reviews * Best Personal Loans * Personal Loan Reviews Homebuying * Best Mortgage Lenders * Current Mortgage Rates * Mortgage Lender Reviews * Guide to Mortgages Insurance * Auto Insurance * Home Insurance * Life Insurance * Pet Insurance * About Us angle-down angle-up Who Is the Motley Fool? * About Us * Contact Us * Investing Philosophy * Motley Fool Money * The Motley Fool Foundation * Reviews * Publishing Standards Fool Podcasts * Podcasts Home * Motley Fool Money * Rule Breaker Investing Social Media * Facebook * Twitter * YouTube * Discussion Boards * CAPS - Stock Picking Community Other Services * Newsroom * Become an Affiliate Partner Our Purpose: To make the world smarter, happier, and richer. Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on Fool.com, personal finance education, top-rated podcasts, and non-profit The Motley Fool Foundation. * Log In * Help * Join The Motley Fool Top 10 Stocks to Buy Now Free Article You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More PREDICTION: THIS WILL BE AMAZON'S NEXT BIG ACQUISITION By Adam Spatacco – Dec 27, 2024 at 5:07AM Key Points * Amazon has made several large-scale acquisitions throughout its history. * In recent years, two of Amazon's quieter acquisitions came from the healthcare space. * I see one emerging telemedicine company as the perfect match to bolster Amazon's healthcare platform. * Buy Alert: Our 10 best stocks to buy right now (see the list) STOCKS MENTIONED AMZN Amazon $221.71 Arrow-Thin-Down (-2.4%) -$5.34 HIMS Hims & Hers Health $26.99 Arrow-Thin-Down (-5.3%) -$1.50 +1 more Show all NASDAQ: AMZN AMAZON Market Cap $2,387B Today's Change Arrow-Thin-Down (-2.35%) -$5.34 Current Price $221.71 Price as of December 27, 2024, 11:50 a.m. ET Amazon may be known for its retail and tech chops, but the company has also built a strong operation in the healthcare realm over the last several years. Amazon (AMZN -2.35%) is primarily known for its e-commerce marketplace and cloud computing infrastructure business. But believe it or not, Amazon also operates within several other end markets including streaming, entertainment, advertising, and more. One way that Amazon has been able to diversify its business over the years is through a series of acquisitions. While the majority of Amazon's buyouts have revolved around the technology sector, the company has made some quiet moves in the healthcare space in recent years. In 2018, Amazon acquired online pharmacy business PillPack for $753 million. Moreover, the company acquired membership-based primary healthcare provider 1Life Healthcare for $3.9 billion in 2023. These two companies have helped Amazon spearhead its healthcare services, primarily through Amazon Pharmacy. Below, I'm going to break down which company I think Amazon could acquire next and explain why I think the deal makes a lot of sense right now. Arrows-In Collapse NASDAQ: AMZN Amazon Today's Change (-2.35%) -US$5.34 Current Price US$221.71 Arrow-Thin-Down YTD1w1m3m6m 1y +49.43% 5y Price VS S&P AMZN KEY DATA POINTS Market Cap $2,387B Day's Range US$220.90 - US$226.03 52wk Range US$144.05 - US$233.00 Volume 10,365,015 Avg Vol 38,065,062 Gross Margin 48.41% Dividend Yield N/A AMAZON SHOULD ACQUIRE HIMS & HERS HEALTH Hims & Hers Health (HIMS -5.26%) is a telemedicine company that specializes in providing a number of lifestyle and wellness products, including treatments for skincare, hair growth, weight loss, anxiety, sexual health, and more. Back in November, Amazon Pharmacy announced that it was expanding its product offerings to include "common health, beauty, and lifestyle concerns" such as anti-aging skincare, hair regrowth, and erectile dysfunction. Right off the bat, I see a lot of overlap between the Hims & Hers platform and Amazon's bolstered offerings through its online pharmacy. Below, I'll dig into what makes Hims & Hers a particularly attractive asset for Amazon's ecosystem. ARE YOU MISSING THE MORNING SCOOP? Start your day ahead of the game with the market’s top stories and key investing insights. Breakfast News delivers it all in a quick, Foolish, and free daily newsletter that lands in your inbox every market morning.. Enter Email Address: By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. Please read our Privacy Statement and Terms & Conditions. Image source: Getty Images. WHY HIMS & HERS HEALTH AND AMAZON COULD BE A MATCH MADE IN HEAVEN Per the chart below, investors can see that the overwhelming majority of revenue for Hims & Hers Health comes from online. And according to the company's 10Q filing, "the majority of our online revenue is subscription-based, where customers agree to be billed on a recurring basis to have products and services automatically delivered to them." Image source: Hims & Hers investor relations. The reason I see Hims & Hers Health as such an attractive asset for Amazon comes down to one thing: Amazon Prime, the subscription service that offers members a host of benefits such as free shipping and access to certain entertainment content through the company's streaming platform. As I referenced above, two of Amazon's major healthcare-related acquisitions in recent years include PillPack and 1Life Healthcare. 1Life Healthcare is an exclusive perk for Prime members, while PillPack and Amazon Pharmacy as a whole are tailored more toward Prime subscribers (although you technically do not need to be a Prime member to access some of Amazon Pharmacy's offerings). I think the obvious synergy opportunity here is for Amazon to roll up Hims & Hers Health's subscriber base into the Prime membership platform -- thereby bolstering its online pharmacy capabilities even further and adding a steady stream of high-margin, recurring revenue in the process. Arrows-In Collapse NYSE: HIMS Hims & Hers Health Today's Change (-5.26%) -US$1.50 Current Price US$26.99 Arrow-Thin-Down YTD1w1m3m6m 1y +220.11% 5y Price VS S&P HIMS KEY DATA POINTS Market Cap $6B Day's Range US$26.70 - US$28.71 52wk Range US$8.09 - US$35.02 Volume 4,163,711 Avg Vol 17,007,547 Gross Margin 70.63% Dividend Yield N/A NOW LOOKS LIKE THE OPPORTUNITY TO GET A DEAL DONE Hims & Hers Health is an interesting case study. Although shares have soared by 216% this year, the stock is actually down by nearly 13% just in December. HIMS data by YCharts One of the bigger trends influencing recent price action for Hims & Hers Health stems from the weight loss market. Right now, glucagon-like peptide-1 (GLP-1) agonists such as Ozempic, Wegovy, Mounjaro, and Zepbound are used to treat diabetes and chronic weight management. All four of these blockbuster drugs are made by either Novo Nordisk or Eli Lilly. While competition in the GLP-1 landscape is sparse, Hims & Hers has been able to find its own unique pocket by offering patients compounded versions of treatments such as Ozempic. Compounded medications are not approved by the Food and Drug Administration (FDA), yet some patients will opt for these knockoffs purely due to their low cost and ease of access. For months now, Novo and Lilly have made public comments about compounded GLP-1 treatments and have been making moves of their own to try to make their weight loss medications more affordable and easier to access. Furthermore, just this week the FDA removed tirzepatide -- the main ingredient in Mounjaro and Zepbound -- from its shortage list. This means that compounding facilities have a limited time (60 to 90 days depending on certain regulatory frameworks) to continue selling compounded GLP-1s. Once this stops, Hims & Hers will likely have a much tougher time penetrating the weight loss market, and its growth could slow down materially. To me, these developments are directly contributing to the current sell-off in Hims & Hers Health stock. With a market capitalization of $6.2 billion, Amazon could easily acquire Hims & Hers Health with cash from the balance sheet. Given the overlap of product offerings between Amazon Pharmacy and Hims & Hers Health, combined with the robust recurring revenue base that Amazon could roll into its Prime membership perks, I see a deal between the two parties as a match made in heaven. WHERE SHOULD YOU INVEST $1,000 RIGHT NOW? Before you put a single dollar into the stock market, consider this: The Motley Fool Stock Advisor Canada analyst team has identified what they believe are the 15 best stocks for investors to buy now. The 15 stocks that made the cut could potentially produce monster returns in the coming years. Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $17,733.03!* Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 36 percentage points since 2013*. See the 15 Stocks *Returns as of 12/26/24 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Adam Spatacco has positions in Amazon, Eli Lilly, and Novo Nordisk. The Motley Fool has positions in and recommends Amazon. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. 5 STOCKS UNDER $50 [FREE REPORT] We hear it over and over from investors, “I wish I had bought Amazon or Netflix when they were first recommended by the Motley Fool. I’d be sitting on a gold mine!” And it’s true. And while Amazon and Netflix have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $50 a share! You can grab a copy of “5 Growth Stocks Under $50” for FREE for a limited time only. Get Your Free Report Related Articles 35% of Warren Buffett's $296 Billion Portfolio Is Invested in 3 Artificial Intelligence (AI) Stocks 1 Unstoppable Stock That Could Join Nvidia, Apple, and Microsoft in the $3 Trillion Club in 2025 Artificial Intelligence (AI) Stocks Roared Higher This Year. Is It Too Late to Invest in This High-Growth Industry? 1 Phenomenal Reason Amazon Will Have a Successful 2025 Meet the Supercharged Artificial Intelligence (AI) Growth Stock That Could Join Apple, Nvidia, and Microsoft in the $3 Trillion Club by 2027 922% Start Your Mornings Smarter! Wake up to the latest market news, company insights, and a bit of Foolish fun—all wrapped up in one quick, easy-to-read email every market day. Enter Email Address: By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. Please read our Privacy Statement and Terms & Conditions PREMIUM INVESTING SERVICES Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. View Premium Services Making the world smarter, happier, and richer. * Facebook Facebook * Twitter Twitter * Linked In LinkedIn * Pinterest Pinterest * YouTube YouTube * Instagram Instagram * Tiktok TikTok © 1995 - 2024 The Motley Fool. All rights reserved. Market data powered by Xignite and Polygon.io. About The Motley Fool * About Us * Careers * Research * Newsroom * Contact * Advertise Our Services * Stock Advisor * Epic * Epic Plus * Fool Portfolios * Fool One * Motley Fool Money Around the Globe * Fool UK * Fool Australia * Fool Canada Free Tools * CAPS Stock Ratings * Discussion Boards * Calculators * Financial Dictionary Affiliates & Friends * Motley Fool Asset Management * Motley Fool Wealth Management * Motley Fool Ventures * Motley Fool Foundation * Become an Affiliate Partner * Terms of Use * Privacy Policy * Disclosure Policy * Accessibility Policy * Copyright, Trademark and Patent Information * Terms and Conditions * Do Not Sell My Personal Information Current This website uses cookies to deliver our services and to analyze traffic. We also share information about your use of our site with advertising and other partners. Privacy Policy Got it Cookie Settings